Flow-dependency of exhaled nitric oxide in children with asthma and cystic fibrosis

European Respiratory Journal

Volumn 14, Issue 4, 1999, Pages 871-875

  Kroesbergen, A ^a,c   Jobsis Q ^a   Bel, E H D ^c   Hop, W C J ^b   De Jongste, J C ^a  

^a SOPHIA CHILDREN S HOSPITAL   (Netherlands)

^b Epidemiology and Biostatisties   (Netherlands)

^c LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Asthma; Children; Cystic fibrosis; Exhaled air; Flow dependency; Nitric oxide

Indexed keywords

NITRIC OXIDE;

AIR ANALYSIS; ARTICLE; ASTHMA; BREATHING RATE; CHILD; CLINICAL ARTICLE; CYSTIC FIBROSIS; EXPIRED AIR; FEEDBACK SYSTEM; FEMALE; FORCED EXPIRATORY VOLUME; HUMAN; MALE; PRIORITY JOURNAL;

ASTHMA; BIOLOGICAL MARKERS; BREATH TESTS; CHILD; CHILD, PRESCHOOL; CYSTIC FIBROSIS; EXPIRATORY RESERVE VOLUME; FEMALE; FORCED EXPIRATORY VOLUME; HUMANS; MALE; NITRIC OXIDE; PEAK EXPIRATORY FLOW RATE; RESPIRATORY PHYSIOLOGY;

EID: 0345035274     PISSN: 09031936     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1399-3003.1999.14d24.x     Document Type: Article

References (16)

1. Lundberg JON, Weitzberg E, Lundberg JM, Alving K. Nitric oxide in exhaled air. Eur Respir J 1996; 9: 2671-2680.
2. Gustafsson LE, Leone AM, Persson MG, Wiklund NP, Moncada S. Endogenous nitric oxide is present in the exhaled air of rabbits, guinea-pigs and humans. Biochem Biophys Res Commun 1991; 181: 852-857.
3. Lundberg JON, Nordvall SL, Weitzberg E, Kollberg H, Alving K. Exhaled nitric oxide in pediatric asthma and cystic fibrosis. Arch Dis Child 1996; 75: 323-326.
4. Balfour-Lynn IM, Laverty A, Dinwiddie R. Reduced upper airway nitric oxide in cystic fibrosis. Arch Dis Child 1996; 75: 319-322.
5. Kharitonov SA, Barnes PJ. Effect of pressure and flow on measurement of exhaled and nasal nitric oxide. Am J Respir Crit Care Med 1997; 155; 4: A825.
6. Silkoff PE, McClean PA, Slutsky AS, et al. Marked flow-dependence of exhaled nitric oxide using a new technique to exclude nasal nitric oxide. Am J Respir Crit Care Med 1997; 155: 260-267.
7. Kharitonov SA, Alving K, Barnes PJ. E.R.S task force: Exhaled and nasal nitric oxide measurement: recommendations. Eur Respir J 1997; 10: 1683-1693.
8. Warner JO, Götz M, Landau LI, et al. Management of asthma: a consensus statement. Arch Dis Child 1989; 64: 1065-1079.
9. Zapletal A, Samanek M, Paul T. Lung function in children and adolescents: Methods, reference-values. Basel; Karger Verlag 1987; 191-197.
10. BMDP Statistical Software manual. Unbalanced repeated measures models with structured covariance matrices. University of California Press, Berkeley, 1992; 1330-1335.
11. Sato K, Sakamaki T, Sumino H, et al. Rate of nitric oxide release in the lung and factors influencing the concentration of exhaled nitric oxide. Am J Physiol 1996; 270: L914-L920.
12. Byrnes CA, Dinarevic S, Busst CA, Shinebourne EA, Bush A. Effect of measurement conditions on measured levels of peak exhaled nitric oxide. Thorax 1997; 52: 697-701.
13. Kharitonov SA, Barnes PJ. Nasal contribution to exhaled nitric oxide during exhalation against a resistance or during breath-holding. Thorax 1997; 52: 540-544.
14. Deykin A, Halpern O, Massaro AF, Drazen JM, Israel E. Expired nitric oxide after bronchoprovocation and repeated spirometry in patients with asthma. Am J Respir Crit Care Med 1998; 157: 769-775.
15. Konstan MW, Hilliard KA, Norvell TM, Berger M. Bronchoalveolar lavage findings in cystic fibrosis patients with stable, clinically mild lung disease suggest ongoing infection and inflammation. Am J Respir Crit Care Med 1994; 150: 448-454.
16. Ho LP, Innes JA, Greening AP. Nitrite levels in breath condensate of patients with cystic fibrosis is elevated in contrast to exhaled nitric oxide. Thorax 1998; 53: 680-684.